News

FDA Upheaval Pushes Some Biotech Firms to Plan Early Trials Out of US
The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...
Infectious Disease Advisor1d
Top FDA Inspection Official to Retire Amid Staff Frustration
Michael Rogers, associate commissioner for inspections and investigations at the US FDA, announced his decision to retire.
JD Supra12d
Mass Layoffs at FDA Could Have the Greatest Impact on Products in Development - The Trump Administration’s First 100 Days
Companies that interact with FDA are likely to find that the layoff of 3,500 employees on April 1, 2025, affects their dealings in a variety of ways.
Fierce Biotech21h
Atara lays off more staff this year despite FDA lifting clinical hold
Atara Biotherapeutics continues to salami slice its head count, this time laying off 30% of what remains of the biopharma's ...
The Associated Press on MSN12d
FDA to rehire fired staffers who booked inspection trips, but other workers remain in limbo
From reproductive rights to climate change to Big Tech, The Independent is on the ground ... those frontline employees are ...
U.S. News & World Report7d
Top FDA Inspection Official to Retire Amid Staff Frustration
But some current and former FDA staff warned these changes could make inspections less effective. In the past, longer trips were seen as a way to group several inspections into one trip ...
Upheaval at FDA pushes some biotech firms to move early trials out of US
Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...